BIOMEA FUSION, INC. RECRUITING STUDIES: • COVALENT-112 – Type 1 Diabetes: COVALENT-112 is a Phase 2 trial designed to examine beta-cell function, insulin sensitivity, and both glucose and lipid metabolism in participants with T1D treated with BMF-219. The study will last around 1 year. Those meeting the eligibility [...]
We are a specialized clinical research company that conducts trials on behalf of our partners in the fields of endocrinology, diabetes, cardiovascular disease, renal disease, and beyond.
PlanIt Research is affiliated with the Endocrine Center of Houston.
CONTACT INFORMATION
10837 Katy Frwy, #200
Houston, TX 77079
713-973-3418
713-973-3415
info@PlanItResearch.com
© Copyright 2023 PlanIt Research | All Rights Reserved